A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Clinical trial NCT00118755 · COMPLETED
Trial details
- NCT number
- NCT00118755
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2009-04-01
- Enrollment
- 435
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.